ARTICLE SYNOPSIS...Has Avigen peaked? The stock gained after an advisory committee of the U.S. National Institute of Health stated it would recommend the initiation of human clinical trials for Avigen's AV201, a gene therapy for advanced Parkinson's disease.
ARTICLE SYNOPSIS...V14:2 (63-64): Basis for Stock Worth by William N. Hosley Estimating a company's value can be the initial filter for identifying trading opportunities. Here's a method to determine a company's value based on earnings growth rates and interest rates.